Physician time
Unhurried consultation, and enough of it to take a proper history and explain a plan — the single thing international patients most often report missing.
A Strategic Framework · Presented for Discussion
Egypt Global Health & Human Potential Initiative
A strategic framework for health, longevity, international patient care, innovation and economic opportunity — proposed as a complementary layer to the national health infrastructure Egypt is already building.
Presented by
Dr. Dalal Akoury, MD
Egyptian-American Physician · Global Health Strategist
Three Ways to Read This
Which door is yours?
The framework asks something different of each participant. Start with the one that describes you — each opens the matching perspective further down the page.
-
For Government
National capability, patient safety and standards
Egypt decides. What this asks of the state, what it protects, and why nothing proceeds without Egyptian authority.
Open this perspective -
For Healthcare Leaders
Clinical governance, collaboration, research and training
Nothing proceeds unless it improves the standard of care. The safeguards, the referral standards and the teaching that would come with them.
Open this perspective -
For Investors & Partners
Evidence first, capital second
A category, a sequence and a set of preconditions. This page is not an offer, a solicitation or a prospectus.
Open this perspective
Where Egypt Already Is
Egypt is already moving. This framework begins from that fact.
Egypt's health sector is not waiting to be started. A national health strategy is in place, a national accreditation body exists and is internationally recognised, a national digital medical-tourism platform has been launched, and Egyptian institutions are already receiving international patients from more than a hundred countries.
Any serious contribution from outside has to begin by acknowledging that, and by asking a narrower and more useful question than “what should Egypt build?” — because much of it is already being built.
The question this framework asks is this: alongside the national infrastructure Egypt is already developing, what complementary layer would make international patients choose Egypt, complete their care well, and stay connected to Egyptian medicine after they return home?
See what already existsNational Momentum
What Egypt Has Already Put in Place
Six national efforts, described here from public information. They are the starting point of this framework, not its product — and none of them is connected to, or has any knowledge of, this proposal.
- i.
Egypt Vision 2030 & the national health strategy
Health system reform, universal health insurance rollout and quality improvement sit inside Egypt's own long-term national development framework. This proposal is written to fit beneath those priorities, not beside them.
- ii.
Ministry of Health and Population
The ministry sets clinical policy, licensing and workforce planning, and publishes the national figures on medical education and the physician workforce that this page cites.
Source [03]
- iii.
Ministry of Tourism and Antiquities
Egypt's tourism authorities already promote therapeutic and medical tourism as a recognised national segment, alongside the hospitality capacity, service culture and destinations that support longer visits.
- iv.
GAHAR — national healthcare accreditation
The General Authority for Healthcare Accreditation and Regulation sets and applies Egypt's national healthcare accreditation standards, and has itself been accredited by the International Society for Quality in Health Care (ISQua).
Sources [04] [05]
- v.
Egypt Healthcare Authority — international patients
Egypt's Healthcare Authority already runs a structured international-patient programme. It reported treating approximately 35,000 international patients from 124 countries in 2025, with roughly $8m in associated revenue — a 76.7% increase on the prior year.
Sources [01] [02] [07]
- vi.
Tour4Cure — national digital platform
A national digital medical-tourism platform intended to connect international patients with accredited Egyptian providers, developed with Egyptian institutional participation. Any new coordination layer should connect to it rather than duplicate it.
Source [06]
How to read this section
These are independent Egyptian national efforts, summarised from publicly available information and cited below. Their appearance on this page is descriptive only. None of the ministries, authorities, platforms or institutions named has endorsed, approved, joined, sponsored or been consulted about this framework, and no relationship with any of them exists.
Why This Proposal, From This Person
An Egyptian physician who built a career abroad, proposing something narrow.
Dr. Dalal Akoury was born and educated in Egypt, and has spent more than four decades practising and teaching medicine in the United States — much of it with patients whose conditions were complex, chronic and difficult to coordinate.
That work is where this framework comes from. The gap it describes is not a market observation; it is what she has watched go wrong for forty years, in the richest health systems in the world: care that is excellent in the room and incoherent everywhere else.
She is not proposing to run, own or direct any part of Egypt's health sector, and she holds no appointment, agreement or authority of any kind. What she offers is convening — bringing the right people into a room, holding the work to an international standard while it is defined, and carrying a proposal between two professional cultures without either being misrepresented to the other.
She has a potential future professional interest in work of this kind, and states it plainly rather than leaving it to be discovered.
Full role, interest and disclosureThe Next Opportunity
The complementary layer
Everything below sits beyond the national infrastructure described above. Each is a coordination, relationship or capability question rather than a construction question — which is precisely why it can be tested cheaply, in one pathway, before anything is built.
Proposed scope
Twelve components of a complementary international layer
- 01
International referral relationships
Formal, reciprocal relationships with physicians and institutions abroad — so that international patients arrive referred, prepared and clinically understood rather than arriving cold through a search engine.
- 02
Longevity medicine
Evidence-guided healthy-ageing, metabolic and functional assessment offered as a defined, disciplined programme with published limits — not as an open-ended promise.
- 03
Preventive medicine
Guideline-concordant screening and risk reduction, structured so that what is tested, why, and what happens with the result are all defined in advance.
- 04
Executive health
A compressed, multidisciplinary assessment for senior professionals and their families — elective, schedulable, measurable, and therefore suitable as a first test of coordination.
- 05
Recovery
Structured post-treatment recovery — rehabilitation, nutrition, monitoring and rest — designed clinically and delivered in settings Egypt already operates well.
- 06
Hospitality integration
Accommodation, family logistics, language support and cultural programming planned around the clinical schedule rather than sold separately from it.
- 07
International follow-up
Scheduled, documented contact after the patient returns home, with a plan their own physician can act on. This is where most international medical travel currently fails.
- 08
Diaspora engagement
Structured participation by Egyptian clinicians, scientists and professionals abroad — as referrers, teachers, collaborators and visiting faculty.
- 09
Education
Continuing professional education, fellowships and structured exchange, designed so that knowledge and people move in both directions.
- 10
Research
Collaborative research in prevention, metabolic health, longevity science and health-systems design, conducted to Egyptian and international ethical standards.
- 11
Technology
The connective layer: secure records exchange, referral routing, remote consultation, follow-up scheduling and outcome tracking — built to interoperate with Egypt's national systems.
- 12
Economic opportunity
Skilled employment, foreign-currency earnings and investment in health-linked development — pursued only at a scale and pace that Egyptian institutions judge appropriate.
Why Egypt
The case rests on capability, not on comparison.
The figures below are published national figures, attributed and linked. The judgements that follow them are described as judgements.
Published national figures
-
≈430,000
Healthcare professionals
CAPMAS, 2020 · all registered healthcare professionals, public and private [08]
-
≈1,800
Hospitals
CAPMAS, 2020 · public, university, military, private and specialist hospitals [08]
-
≈13,000
Physicians graduating each year
Minister of Health and Population, 2026 · new medical graduates per year [03]
-
35,000
International patients from 124 countries, 2025
Egypt Healthcare Authority, 2025 · patients treated in its own facilities during 2025 [01]
International patients from 124 countries, 2025 — This is a single-year figure for one authority's facilities, not a national total and not cumulative. Definitions of “medical tourist” differ between sources, so it should not be compared with figures published elsewhere without checking what each one counts.
Figures are reproduced as published by their sources and are not adjusted, projected or combined. Full citations appear in the Sources section at the foot of this page. Where a figure is several years old, it is labelled with its year rather than presented as current.
What Egypt genuinely brings
A large, established clinical workforce; a substantial and expanding hospital base; deep specialty depth across oncology, cardiology, orthopaedics, fertility, ophthalmology, transplantation and rehabilitation; and a national accreditation body that is itself internationally accredited.
Alongside that: a mature hospitality industry with the service culture and capacity to support longer stays, restorative settings on the Mediterranean and Red Sea, and a geography within convenient reach of Africa, the Middle East, Europe and much of Asia. These are strategic advantages rather than measured claims, and they are offered here as such.
What Egypt is not being asked to do
This framework does not propose that Egypt build new hospitals, create new specialties, or reorganise its health system to serve international patients. Domestic health priorities are, and should remain, the country's first concern.
What is proposed is narrower and cheaper: a coordination, referral and follow-up layer that connects capabilities Egypt already holds, tested first in a single pathway small enough that stopping it costs almost nothing.
Medical Talent & Diaspora
Real strength, and real pressure, in the same workforce.
Egypt produces physicians at a scale few countries in the region match. The Minister of Health and Population has stated that Egypt currently graduates around 13,000 doctors annually, and that this figure may rise to about 22,000 as private university capacity expands.
The same public reporting shows the pressure alongside the strength: physicians working in government hospitals declined from 122,400 in 2023 to 120,400 in 2024. Egyptian clinicians are also present in senior roles across health systems in the Gulf, Europe and North America — a genuine national asset abroad, and a genuine staffing pressure at home.
- Production capacity — approximately 13,000 physicians graduating annually, potentially rising to around 22,000. [03]
- Workforce pressure — government-hospital physicians down 1.7%, from 122,400 (2023) to 120,400 (2024). [03]
- Diaspora expertise — Egyptian physicians and scientists hold senior positions in leading institutions internationally, and are a natural referral, teaching and research bridge.
- Shortages are real — and are a matter for Egyptian workforce policy, not for a proposal of this kind to resolve.
What this framework does not claim
This framework does not claim to solve physician emigration or workforce shortage. Those are national policy questions of far greater scale. What it proposes is narrower: that structured international referral, teaching, research and diaspora participation may make staying in Egypt professionally more attractive at the margin. If a pilot proceeds, retention should be treated as a secondary outcome to be measured — reported honestly whether the effect is positive, negligible or absent — never as a promised result.
Value Density
World-class value, not discount medicine.
Competing on price is a losing position: it attracts the most price-sensitive patients, invites comparison with the cheapest market of the moment, and puts constant downward pressure on quality. The proposition here is the opposite — that Egypt can offer more of what patients actually cannot buy elsewhere.
Coordinated diagnostics
Tests selected deliberately and sequenced sensibly, rather than accumulated department by department.
Access
Appointments, imaging and specialist opinions within days rather than months, without a queue that penalises the complex case.
Multidisciplinary review
Specialists who confer with one another about the same patient and arrive at one coherent recommendation.
Navigation
A named, accountable coordinator who owns the patient's pathway end to end, in a language the patient understands.
Hospitality
Accommodation, recovery, family support and logistics planned around the clinical schedule — an area of established Egyptian strength.
Continuity
A documented plan and scheduled follow-up that continue after the patient has flown home.
Time · Coordination · Access · Continuity
The International Patient Journey
Four stages. One accountable pathway.
Each stage below already exists in Egypt in some form. What is proposed is to govern them as a single continuous experience, with one party accountable for the whole of it.
Before Egypt
Case review by an Egyptian clinician before travel, correct test selection, specialist matching, honest cost and timeline expectations, records transferred in advance, visa and travel coordination.
In Egypt
Precision diagnostics, specialists who confer with one another, interpretation delivered in the patient's own language, and one named coordinator accountable throughout.
Recovery
Structured rehabilitation, nutrition, monitoring and rest in settings designed for restoration, with the accompanying family supported alongside the patient.
After Egypt
Complete records transferred to the patient's own physician in a usable form, a written plan that physician can act on, and scheduled follow-up contact at defined intervals.
Why the fourth stage matters most
International medical travel most commonly fails after the patient goes home: records that never arrive in usable form, no continuity with the home physician, complications managed by someone who was not part of the original decision, and no way to know whether the treatment actually worked. Continuity after return is therefore treated here as one of the framework's principal differentiators and as a measured outcome of any pilot — not as an optional courtesy at the end.
Human Potential
Human Potential has to mean something specific.
Used loosely, the phrase is branding. Used precisely, it is a list of things that can be built, staffed, funded and measured. Nine of them are set out below.
- i.
Talent development
Structured training in international patient care, coordination, communication and quality methods — skills that are learnable, teachable and currently in short supply everywhere.
- ii.
Retention
Professional roles, teaching opportunities and research participation that give clinicians reasons to build careers in Egypt. Measured as an outcome, never promised as a result.
- iii.
Diaspora engagement
Defined roles for Egyptian clinicians and scientists abroad — referral partners, visiting faculty, research collaborators, second-opinion contributors.
- iv.
Research
Collaborative studies in prevention, metabolic health, longevity and health-systems design, with Egyptian investigators as principals rather than as sites.
- v.
Education
Continuing medical education, fellowships and exchange programmes with international faculty teaching in Egypt and Egyptian faculty teaching abroad.
- vi.
Quality systems
Practical quality-management capability aligned with national accreditation requirements — the unglamorous discipline that makes everything else defensible.
- vii.
Records interoperability
Secure, standards-based exchange of medical records between participating institutions, national systems and the patient's own physician abroad.
- viii.
Navigation
A trained, accountable coordination profession — currently informal almost everywhere, and one of the clearest opportunities to lead rather than follow.
- ix.
Outcome measurement
Defined metrics, honest reporting and published results, including results that are disappointing. Without this, none of the above can be assessed at all.
The Proposed Platform
Three layers, clearly labelled.
Confusion about what exists and what does not is the fastest way to lose institutional credibility. Every component is therefore placed in one of three explicit categories.
Integrates with existing national systems
Built onto what Egypt already operates
These components would connect to Egyptian national infrastructure rather than replace or duplicate it. Any such connection would require the agreement of the relevant Egyptian authority — none has been sought or given.
- Alignment with GAHAR national accreditation standards as the basis for institutional participation
- Interoperability with Tour4Cure and other national digital health-tourism infrastructure
- Full compliance with Egyptian licensing, regulatory and professional requirements
- Medical-records exchange conforming to Egyptian national systems and data-protection requirements
- Coordination with existing international-patient programmes run by Egyptian health authorities
Proposed new layer
The complementary capabilities
None of these exists today. Each is a proposal to be designed, costed, approved and tested — first at the smallest scale that can produce a real answer.
- International referral relationships with physicians and institutions abroad
- Patient navigation and case coordination, with named accountability for each patient
- Executive-health and longevity pathway design, with published scope and published limits
- Multilingual consent, interpretation and patient-communication standards
- Structured integration of recovery and hospitality around the clinical schedule
- Post-return follow-up protocols with the patient's own physician
- Outcome measurement, adverse-event reporting and published performance data
Later phase — subject to evidence
Only after the evidence exists
Nothing in this layer should be designed, promoted, financed or announced until a pilot has produced measured results and the appropriate Egyptian authorities have approved proceeding.
- Dedicated recovery and longevity destinations on the Mediterranean or Red Sea
- Formal research and innovation partnerships with international institutions
- A physician education academy with structured international faculty exchange
- A formal diaspora clinical exchange programme
- Health-linked development, districts or residences of any kind
Status of every component above
Every component on this page is proposed for discussion. None is an existing programme, agreement, partnership, licence, entity or institutional commitment, and nothing here should be read as suggesting otherwise. Each would have to be defined, scoped, costed and approved with the appropriate Egyptian authorities, institutions and clinical leadership before any design, announcement, financing or clinical activity of any kind.
Why Executive Health First
The pilot is a capability test, not the end market.
The first pathway is chosen for what it can teach, not for what it can earn. If the coordination works there, it can be extended. If it does not, very little has been risked.
Why this pathway
Executive health is proposed as the first pathway because it is elective, lower-acuity than many complex treatment pathways, comparatively measurable, multidisciplinary, and suitable for testing navigation, coordination, informed consent, records exchange, follow-up and patient experience before considering higher-complexity pathways.
It also fails safely. An elective assessment that is poorly coordinated produces a disappointed visitor and a clear list of things to fix. The same coordination failure inside a complex surgical or oncological pathway is a different order of problem entirely — which is exactly why the coordination should be proven somewhere else first.
Screening safeguards
An executive-health pathway is only defensible if it is disciplined about what it tests and why. The following would be built in from the start, not added later:
- Guideline-concordant screening only — tests are included because evidence supports them for that patient, not because they are available or impressive.
- No indiscriminate whole-body imaging or untargeted panel testing.
- Pre-test counselling covering false positives, incidental findings and the realistic limits of screening.
- A defined, funded pathway for every abnormal or incidental result, agreed before the programme accepts its first patient.
- Informed consent in the patient's own language, documenting what the assessment does and does not establish.
- Audit of downstream investigation, so that over-investigation is detected and corrected rather than quietly monetised.
What Must Be Solved
Ten problems that would end this if left unsolved.
These are the reasons international health initiatives fail. Each is paired here with the response a pilot would have to design in advance, and with how it would be measured.
Challenge
Quality variance between institutions
Pilot response
Participation restricted to institutions meeting published, nationally-recognised accreditation criteria, with criteria applied consistently and reviewable by participants.
Measurement
Proportion of pathway volume delivered by accredited institutions; complaint and adverse-event rates by institution.
Challenge
Cross-border liability
Pilot response
Written allocation of clinical and legal responsibility between the referring physician abroad, the Egyptian institution and any coordinating party, reviewed under Egyptian law before any patient is accepted.
Measurement
Signed liability framework in place before first patient; number of disputes and time to resolution.
Challenge
Insurance and payment
Pilot response
Transparent, itemised pricing agreed in advance; explicit statement of what international insurers will and will not reimburse; no ambiguity about who pays for complications.
Measurement
Variance between quoted and final cost; proportion of patients with unexpected charges.
Challenge
Multilingual consent
Pilot response
Consent documents and clinical discussions delivered in the patient's own language by qualified medical interpreters, with comprehension confirmed and documented rather than assumed.
Measurement
Proportion of consents taken in the patient's first language; documented comprehension checks; patient-reported understanding.
Challenge
Over-screening and incidental findings
Pilot response
Guideline-concordant testing only, pre-test counselling on incidental findings, and a defined follow-up pathway for every abnormal result agreed before the programme opens.
Measurement
Rate of incidental findings; proportion resolved to a documented endpoint; audit of downstream investigation volume.
Challenge
Medical records and interoperability
Pilot response
Structured, standards-based records exchange with the patient's own physician, conforming to Egyptian national systems and data-protection requirements.
Measurement
Proportion of patients whose complete records reach their home physician in usable form within a defined window.
Challenge
Follow-up after return
Pilot response
Scheduled follow-up contact at defined intervals, with a written plan the home physician can act on, and a named party accountable for making the contact happen.
Measurement
Follow-up completion rate at 30, 90 and 365 days; proportion of home physicians who confirm receipt of a usable plan.
Challenge
Reputational risk to Egypt
Pilot response
Conservative claims, published limits, no guaranteed outcomes, and an agreed protocol for handling adverse events and complaints openly rather than defensively.
Measurement
Independent review of all published material; adverse-event disclosure rate; time from complaint to substantive response.
Challenge
Domestic patient capacity
Pilot response
Volume caps set by the participating Egyptian institutions themselves, with capacity effects evaluated by those institutions and monitored throughout.
Measurement
Domestic waiting times, theatre and clinic utilisation, and domestic access measures tracked before, during and after the pilot.
Challenge
Governance and accountability
Pilot response
Named responsibility for each component, defined decision rights, disclosed commercial relationships, and a written stopping rule agreed before the pilot begins.
Measurement
Governance framework documented and published; adherence reviewed at each phase gate.
A Practical First Step
A proposed 90-Day Strategy Council
Before anything is designed, financed or announced, the sensible first move is a short, disciplined assessment by a small group of the right people, hosted by an appropriate Egyptian institution.
What is proposed
A working council of approximately ten to fifteen participants drawn from Egyptian government, medicine, academia, hospitality, development and technology — small enough to reach conclusions, senior enough for those conclusions to be useful.
It would convene for a defined ninety-day period with a fixed agenda and a written output: an assessment of what Egypt can credibly offer today, what would need to be added, what the risks are, and whether a single pilot pathway is worth designing at all.
What this is not
- Proposed only. The council is a proposal in this document and nothing more.
- Not established. It does not exist. It has no charter, no secretariat, no budget and no meetings scheduled.
- No members appointed. Nobody has been invited, approached, nominated or appointed to it.
- Hosted and constituted by Egypt. Any council would be hosted by an appropriate Egyptian institution, and that host — not Dr. Akoury — would determine its membership, its terms of reference and its chair.
- It recommends; it does not govern. A council of this kind can produce analysis and recommendations. It has no authority over Egyptian policy, institutions, regulation or clinical practice, and would claim none.
Seven questions the ninety days would answer
Map what genuinely exists today — clinical, accreditation, hospitality, digital and regulatory — at what standard, and where, working from Egyptian institutional sources.
Identify the regulatory, licensing, liability, insurance and data-protection requirements any international patient pathway would have to satisfy under Egyptian law.
Determine whether a complementary coordination layer is actually needed, or whether existing national infrastructure already covers the gap.
If it is needed, design one pathway end to end — from referral abroad through assessment, treatment where applicable, recovery and long-term follow-up.
Define patient-safety, consent, navigation, records and follow-up standards, and the domestic-capacity safeguards that would apply.
Define the outcome measures, the reporting commitments and the explicit stopping rule under which the pilot would be halted.
Produce a written recommendation to the host institution: stop, refine, or proceed to a bounded pilot.
Funding and administration of any 90-day assessment
Funding, administrative support and secretariat arrangements for any 90-Day assessment would be established transparently with the prospective Egyptian host before commencement. No funding arrangement is established by this proposal. No sponsor, donor, budget or financial commitment exists, is implied, or is being sought through this page.
The Day-90 Decision
Three outcomes. Scale is not one of them.
The council's output is a recommendation to its Egyptian host, which decides. Three outcomes are available, and each is a legitimate result.
- Outcome 01
Stop
The assessment concludes that the complementary layer is not needed, not feasible, not appropriate at this time, or better delivered by existing national institutions. The work ends and the findings are documented honestly. This is a successful outcome, not a failure.
- Outcome 02
Refine
The concept has merit but the design, scope, governance, safeguards or partners are not yet right. The framework is revised and reassessed before any pilot is authorised.
- Outcome 03
Pilot
A single, bounded, capped pilot pathway is authorised by the appropriate Egyptian authorities, with published outcome measures, a defined duration and an agreed stopping rule.
Why “scale” is not a Day-90 option
Scaling is not available as a Day-90 decision, and this page does not present it as one. Any expansion beyond a single bounded pilot could only be considered after that pilot has run, after its measured outcomes have been reviewed by the participating Egyptian institutions, and after the relevant Egyptian regulatory and clinical authorities have separately approved proceeding. The sequence is: assessment → pilot → measured evidence → approvals → and only then any question of scale.
Governance & Integrity
How this would be held to account.
A proposal of this kind earns the right to be taken seriously only if the constraints are stated before the opportunity is. These are the commitments that would frame every stage.
Egyptian sovereignty
Egypt determines its own health policy, priorities and partners. Nothing proposed here seeks, assumes or implies any authority over Egyptian decisions, and no external party would hold any.
Egyptian law
All activity would be conducted under Egyptian law, with legal review completed before any clinical, commercial or contractual step is taken.
Egyptian licensing
All clinical care would be delivered by clinicians licensed to practise in Egypt, within their scope of practice, under Egyptian professional regulation.
Egyptian clinical governance
Clinical oversight, credentialling, morbidity review and incident management would sit with Egyptian institutions and Egyptian clinical leadership.
Patient safety first
No pathway or component proceeds unless patient safety is designed in from the outset, independently reviewable, and backed by a stopping rule agreed in advance.
Evidence-based care
Clinical content grounded in evidence. Integrative, functional and regenerative approaches positioned as complementary to — never a replacement for — conventional medical care.
Accreditation
Institutional participation conditional on meeting published, nationally-recognised accreditation standards, applied consistently and open to review.
Transparency
Published participation criteria, published outcome measures, and published results — including results that are disappointing or that lead to the work being stopped.
Privacy and data protection
Patient data handled to Egyptian and international standards of privacy, security, consent and cross-border transfer, with no secondary use without explicit consent.
Ethical referral
Referral and navigation decisions made on clinical grounds alone. Any commercial relationship that could influence a referral disclosed to the patient rather than concealed.
Clear accountability
Named responsibility for each component, defined decision rights, disclosed interests, and measurable outcomes reviewed at each phase gate.
Domestic patient capacity
Any pilot should be designed to avoid material displacement of care for Egyptian patients. Capacity effects should be evaluated by participating Egyptian institutions and monitored as part of the pilot's performance framework.
The Convener
Who is proposing this, and on what basis.
Dr. Dalal Akoury was born and educated in Egypt and has spent more than four decades in medicine — in clinical practice, in medical education, and in the care of patients with complex and chronic conditions. She is the founder of AWAREmed, a physician-led practice in the United States, and an international educator, author and speaker.
She is proposing this framework because she believes the specific gap it describes — international referral, coordination and long-term follow-up — is real, is unsolved in most markets, and is one that Egypt is unusually well placed to address using capabilities it already has.
She is not proposing to run, own or direct any part of Egypt's health sector. What she offers is convening: the ability to bring people into a room, to hold the work to an international standard while it is being defined, and to carry a proposal between two professional cultures without either one being misrepresented to the other.
What she contributes
- An Egyptian-American bridge — born and educated in Egypt, a career built in the United States, and fluency in the professional expectations of both.
- Medical experience — more than four decades in clinical practice, medical education and the management of complex and chronic conditions.
- International relationships — working relationships across medicine, education, entrepreneurship and international business that can be used for introductions and convening.
- Programme architecture — the design of the framework itself: its structure, its safeguards, its measurement approach and its stopping rules.
- Convening — assembling the right participants around a defined question, and keeping the work honest about what is known and what is not.
“I did not come home to build another clinic. I came home to ask a narrow question carefully, and to accept the answer Egypt gives.”
Dr. Dalal Akoury, MDEgyptian-American Physician · Global Health Strategist
Role, interest and disclosure
Dr. Akoury holds no governmental appointment, no ownership, no compensation, no equity, no exclusivity and no formal partnership in connection with this framework. No agreement of any kind exists with any Egyptian ministry, authority, institution, hospital, company or individual. Her role at present is limited to authoring and presenting this proposal.
She has a potential future professional interest in work of this kind, and states it here rather than leaving it to be discovered. Any future professional or commercial role would require transparent negotiation, due diligence, independent legal review, appropriate governance and conflict-of-interest management, Egyptian regulatory approval where applicable, and a written agreement — none of which exists, is under discussion, or is created by this page.
International business convening
Dr. Akoury's international professional network includes JT Foxx, a business coach and event organiser who convenes international entrepreneurs and executives. Any involvement would be limited to introductions and convening at the business level. He holds no clinical, governmental, regulatory or decision-making role in this framework; no partnership, investment commitment or Egyptian institutional relationship is stated or implied; and nothing on this page should be read as a promotion of any programme, event or commercial offering.
Stakeholder Perspectives
What this would mean for each participant.
A framework of this kind is only worth examining if every participant can see what it asks of them and what it offers in return. Select a perspective.
Egypt decides. This is a proposal, not a plan requiring approval.
Presented to national and institutional leadership for consideration. Nothing here asks Egypt to commit to anything, and nothing here would proceed without Egyptian authority.
- Egyptian sovereignty is the starting condition, not a concession — Egypt sets health policy, priorities, partners and pace, and would hold every decision right at every stage.
- Patient safety designed in from the first day, independently reviewable, with a written stopping rule agreed before any pilot begins.
- National standards strengthened rather than bypassed — participation conditional on meeting Egypt's own accreditation requirements, applied consistently and open to review.
- National capability built where it is currently thin: coordination, navigation, records exchange, consent practice and outcome measurement — capabilities that serve Egyptian patients too.
- Domestic capacity protected by design: volume caps set by the participating Egyptian institutions themselves, with capacity effects evaluated by those institutions and monitored throughout.
- Skilled employment and, in time, export earnings — real but secondary, and only at a scale and pace Egyptian institutions judge appropriate.
Nothing proceeds unless it improves the standard of care.
Offered to Egypt's physicians and scientific leadership for examination — the coordination problem it describes, the safeguards it proposes, and the question of whether one carefully designed pathway is worth building at all.
- Clinical governance, credentialling, morbidity review and incident management remain with Egyptian institutions and Egyptian clinical leadership.
- Guideline-concordant screening only, with pre-test counselling, a defined pathway for every incidental finding, and an audit of downstream investigation.
- Structured collaboration between accredited Egyptian centres, working to shared standards and shared records rather than in isolation.
- International teaching, fellowship and research partnerships with Egyptian investigators as principals rather than as study sites.
- Genuine continuity of care: patients properly prepared before arrival and properly followed after departure, with records their own physician can act on.
- Integrative, functional and regenerative approaches positioned as complementary to — never a replacement for — conventional medical care.
A visitor who stays three weeks, not three days.
Health travel changes the economics of a visit: longer stays, off-season demand, an accompanying family, and services Egyptian hospitality already delivers exceptionally well.
- Longer average stays and lower seasonality than conventional leisure travel, driven by clinical schedules rather than holiday calendars.
- An accompanying party — spouse, family, sometimes staff — travelling and spending alongside the patient.
- New service lines in clinical nutrition, structured recovery, rehabilitation support and family accommodation.
- Recovery and restoration settings along the Mediterranean and Red Sea that extend well beyond resort tourism.
- Hospitality planned around the clinical schedule rather than sold beside it — which is a coordination change, not a construction project.
- Nothing built or committed before a pilot has shown that the demand is real and can be served well.
Evidence first. Capital second.
This page is not an offer, a solicitation or a prospectus, and nothing on it should be read as one. It describes a category and a sequence — nothing more.
- Health-linked development behaves differently from leisure or residential product: occupancy is less seasonal and demand is driven by need rather than discretion.
- The categories are established internationally and largely unbuilt in this region — longevity communities, recovery residences, medical and innovation districts.
- Every one of them sits in the later-phase layer of this framework, subject to evidence and to Egyptian approval.
- The sequence is deliberate: assessment, then a bounded pilot, then measured results, then approvals — and only then any question of capital deployment.
- No return is promised, guaranteed or implied, and no investment vehicle, entity or instrument exists.
- Any commercial relationship that could influence a clinical referral would be disclosed to the patient rather than concealed.
A referral relationship worth putting your name to.
For physicians, institutions, insurers and coordinators abroad who would be asked to send patients to Egypt — and who carry the reputational consequence if it goes badly.
- Participation restricted to institutions meeting published, nationally-recognised accreditation criteria.
- Case review before travel, so a patient is only accepted when the pathway is genuinely appropriate for them.
- Written allocation of clinical and legal responsibility between the referring physician, the Egyptian institution and any coordinating party.
- Complete records returned to the referring physician in a usable form, within a defined window, in their working language.
- Scheduled follow-up at defined intervals after the patient returns, with outcomes reported back rather than left unknown.
- Published outcome measures and adverse-event reporting — including results that are disappointing.
A defined role, not a sentiment.
Egyptian clinicians, scientists and professionals abroad are among the country's most valuable assets. Goodwill alone has never been enough — what has been missing is a structure through which to contribute.
- Referral partner: sending appropriate international patients into a pathway whose standards are visible and reviewable.
- Visiting faculty: teaching in Egypt on defined rotations rather than as one-off visits.
- Research collaborator: co-investigating with Egyptian colleagues, with authorship and leadership shared honestly.
- Second-opinion contributor: adding specialist review to complex cases without either party losing accountability.
- Standards and systems: bringing quality-management, interoperability and measurement practice learned abroad.
- Retention effect: if working in Egypt becomes more connected to international medicine, staying becomes a more attractive professional choice. This is measured as an outcome, never promised as a result.
Strategic Briefing
Request a strategic briefing.
For government bodies, health authorities, hospitals and clinical institutions, universities and research centres, tourism and hospitality leadership, developers, family offices and international partners considering whether this framework merits examination.
Every enquiry is read personally by Dr. Akoury's office and answered directly. Correspondence is treated as confidential and is not circulated further without your agreement. Enquiries from government bodies and public institutions are reviewed manually and are never added to any mailing list, marketing sequence, event promotion or investment communication of any kind.
Institutional and professional enquiries
Every enquiry is read personally by Dr. Akoury's office. Correspondence is treated as confidential and is not circulated further without your agreement.
Enquiries from government bodies and public institutions are reviewed manually and answered directly. They are never added to any mailing list, marketing sequence, event promotion or investment communication of any kind.
Office of Dr. Dalal Akoury
info@awaremed.com
Telephone
+1 (423) 430-6170
Languages
English · العربية · Français · Español
Thank you — your request has been received.
Dr. Akoury's office will review your message personally and respond directly. Correspondence of this kind is treated as confidential.
If your matter is time-sensitive, you may also write to info@awaremed.com.
Sources
Every figure on this page, and where it comes from
Figures are reproduced as published. Where a source is several years old, the year is stated rather than the figure being presented as current.
- 01Medical tourism in Egypt jumps 76.7%, generating $8m in 2025Daily News Egypt · 2026
- 02“We Care for You” — international patients from 50+ countriesEgypt Healthcare Authority · 2025
- 03
- 04Egypt’s GAHAR receives ISQua accreditationAhram Online
- 05
- 06
- 07Official portalGeneral Authority for Healthcare (GAH)
- 08
Institutional names appear here as sources of published information only. Their inclusion does not indicate any relationship with, knowledge of, or endorsement of this framework.